Development of pathogenic concepts in glutaryl-CoA dehydrogenase deficiency: the challenge

S I Goodman1

  • 1Department of Pediatrics, University of Colorado Health Sciences Center, Denver, CO 80045, USA. stephen.goodman@uchsc.edu

Insights

This review explores the biochemical and molecular underpinnings of glutaric acidaemia type I. It also examines the pathogenesis of acute striatal necrosis, a key feature in early childhood.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neurology

Background:

  • Glutaric acidaemia type I is a rare genetic metabolic disorder.
  • It is characterized by the accumulation of specific organic acids.
  • Neurological complications, particularly acute striatal necrosis, are common in affected children.

Purpose of the Study:

  • To provide a foundational understanding of glutaric acidaemia type I.
  • To discuss the biochemical and molecular mechanisms involved.
  • To explore the pathogenesis of acute striatal necrosis.

Main Methods:

  • This is a review article.
  • It synthesizes existing literature on glutaric acidaemia type I.
  • Key biochemical pathways and molecular targets are discussed.

Main Results:

  • The review lays the groundwork for understanding glutaric acidaemia type I.
  • It highlights the complexity of its biochemical basis.
  • It prepares for detailed discussions on pathogenesis.

Conclusions:

  • A comprehensive understanding of the biochemical and molecular aspects is crucial.
  • Further research into pathogenesis can guide therapeutic strategies.
  • This review serves as a basis for future investigations.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...